In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 0.02 a new company low.

Within Major Pharmaceutical Preparations industry 41 other companies have achieved higher Quick Ratio than Neptune Wellness Solutions Inc in third quarter 2023. While Quick Ratio total ranking has improved so far during the Q3 2023 to 809, from total ranking in the second quarter 2023 at 3972.

Explain Quick Ratio?
How much Cash & cash equivalents NEPT�s has?
What are NEPT�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NEPT/financial-strength

https://api.csimarket.com/api/v1/companies/NEPT/fundamentals

https://api.csimarket.com/api/v1/companies/NEPT/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

NEPT Quick Ratio	(Dec 31 2023) Q3	(Sep 30 2023) Q2	(Jun 30 2023) Q1	(Mar 31 2023) Q4	(Dec 31 2022) Q3
Y / Y Current Liabilities Change	169.77 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	-63.45 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	0.02	Subscribe	Subscribe	Subscribe	Subscribe
NEPT's Total Ranking	# 809	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	31.1 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	-73.77 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2023 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 42
Healthcare Sector	# 100
Overall Market	# 809

Quick Ratio Statistics
High	Average	Low
0.96	0.42	0.02
(Mar 31 2020)		(Dec 31 2023)

Financial Statements
Neptune Wellness Solutions Inc 's Current Liabilities	$ 60 Millions	Visit NEPT's Balance sheet
Neptune Wellness Solutions Inc 's Cash & cash equivalent	$ 1 Millions	Visit NEPT's Balance sheet
Source of NEPT's Sales		Visit NEPT's Sales by Geography

Cumulative Neptune Wellness Solutions Inc 's Quick Ratio

NEPT's Quick Ratio for the trailling 12 Months

NEPT Quick Ratio	(Dec 31 2023) 12 Months	(Sep 30 2023) 12 Months	(Jun 30 2023) 12 Months	(Mar 31 2023) 12 Months	(Dec 31 2022) 12 Months
Y / Y Current Liabilities TTM Growth	100.06 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	-52.46 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	0.04	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 4718	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	20.25 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	-18.72 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to NEPT Financial Strength Comparisons >> Go to Compare NEPT Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q3 2023 to $59.52 millions, cumulative Quick Ratio decreased to 0.04 below the Neptune Wellness Solutions Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 573 other companies have achieved higher Quick Ratio than Neptune Wellness Solutions Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3073 to 4718.

Explain Quick Ratio?
How much Cash & cash equivalents NEPT�s has?
What are NEPT�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 574
Healthcare Sector	# 1163
Within the Market	# 4718

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.27	0.64	0.05
(Dec 31 2021)		(Dec 31 2023)

Companies with similar Quick Ratio in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry	Quick Ratio	Dec 31 2023 MRQ Cash & cash equivalent	Dec 31 2023 MRQ Current Liabilities
Cnbx Pharmaceuticals Inc	0.05	$ 0.082 Millions	$ 1.560 Millions
Orgenesis Inc	0.05	$ 0.837 Millions	$ 16.407 Millions
Emmaus Life Sciences Inc	0.04	$ 2.547 Millions	$ 60.733 Millions
Semnur Pharmaceuticals Inc	0.04	$ 0.205 Millions	$ 5.098 Millions
Kairos Pharma Ltd	0.04	$ 0.093 Millions	$ 2.401 Millions
Procaps Group S a	0.04	$ 17.514 Millions	$ 494.714 Millions
Rain Enhancement Technologies Holdco Inc	0.03	$ 0.037 Millions	$ 1.128 Millions
One World Products Inc	0.03	$ 0.086 Millions	$ 2.978 Millions
Regen Biopharma Inc	0.02	$ 0.124 Millions	$ 5.247 Millions
Oncotelic Therapeutics Inc	0.02	$ 0.170 Millions	$ 7.595 Millions
Neptune Wellness Solutions Inc	0.02	$ 1.251 Millions	$ 59.519 Millions
Propanc Biopharma Inc	0.02	$ 0.072 Millions	$ 3.762 Millions
Lunai Bioworks Inc	0.02	$ 0.244 Millions	$ 13.758 Millions
Citius Oncology Inc	0.02	$ 0.033 Millions	$ 2.046 Millions
Scienture Holdings Inc	0.01	$ 0.152 Millions	$ 10.937 Millions
60 Degrees Pharmaceuticals Inc	0.01	$ 0.265 Millions	$ 19.434 Millions
Hst Global Inc	0.01	$ 0.002 Millions	$ 0.114 Millions
Provectus Biopharmaceuticals Inc	0.01	$ 0.077 Millions	$ 7.420 Millions
Accustem Sciences Inc	0.01	$ 0.021 Millions	$ 2.246 Millions
Actavia Life Sciences Inc	0.01	$ 0.019 Millions	$ 2.130 Millions
Nexien Biopharma Inc	0.01	$ 0.003 Millions	$ 0.317 Millions
Bioxytran Inc	0.01	$ 0.026 Millions	$ 3.244 Millions
Os Therapies Incorporated	0.01	$ 0.039 Millions	$ 4.933 Millions
Biostax Corp	0.01	$ 0.035 Millions	$ 4.563 Millions
Kaya Holdings Inc	0.01	$ 0.029 Millions	$ 5.625 Millions
Cingulate Inc	0.01	$ 0.052 Millions	$ 10.226 Millions
Jupiter Neurosciences Inc	0.00	$ 0.029 Millions	$ 5.798 Millions
Cell Source Inc	0.00	$ 0.022 Millions	$ 4.531 Millions

Date modified: 2026-10-07T00:41:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.